Article info

Download PDFPDF
Extended report
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

Authors

  1. Correspondence to Dr Bente Glintborg, Department of Rheumatology, Gentofte University Hospital, Niels Andersensvej 65, Hellerup 2900, Denmark; glintborg{at}dadlnet.dk
View Full Text

Citation

Glintborg B, Østergaard M, Krogh NS, et al
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

Publication history

  • Received April 26, 2012
  • Accepted July 19, 2012
  • First published August 31, 2012.
Online issue publication 
May 30, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.